Advertisement

Citation tools

Jones, Jeffrey A. et al "Phase 1b Results of a Phase 1b/2 Study of Obinutuzmab, Ibrutinib, and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)." Blood 128.22 (2016): 639. Web. 18 July. 2019.